Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-01-20 Sale | 2023-01-24 4:08 pm | Pear Therapeutics Inc. | PEAR | Brenner Erin K. Chief Product Dev. Officer | 8,690 | $1.13 | $9,820 | 43,310 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-02-15 Option Award | 2023-02-17 4:14 pm | N/A N/A | Pear Therapeutics Inc. | PEAR | Brenner Erin K. Chief Product Dev. Officer | 952,380 | $0 | 952,380 (Direct) | View |
| 2023-01-14 Exercise | 2023-01-18 6:42 pm | N/A N/A | Pear Therapeutics Inc. | PEAR | Brenner Erin K. Chief Product Dev. Officer | 22,000 | $0 | 96,667 (Direct) | View |
| 2022-12-09 Exercise | 2022-12-09 5:02 pm | N/A N/A | Pear Therapeutics Inc. | PEAR | Brenner Erin K. Chief Product Dev. Officer | 15,000 | $1 | 120,234 (Direct) | View |
| 2022-12-09 Exercise | 2022-12-09 5:02 pm | N/A 2028-09-20 | Pear Therapeutics Inc. | PEAR | Brenner Erin K. Chief Product Dev. Officer | 15,000 | $0 | 120,234 (Direct) | View |
| 2022-05-25 Exercise | 2022-05-27 4:02 pm | N/A N/A | Pear Therapeutics Inc. | PEAR | Brenner Erin K. Chief Product Dev. Officer | 15,000 | $1 | 120,234 (Direct) | View |
| 2022-05-25 Exercise | 2022-05-27 4:02 pm | N/A 2028-09-20 | Pear Therapeutics Inc. | PEAR | Brenner Erin K. Chief Product Dev. Officer | 15,000 | $0 | 120,234 (Direct) | View |
| 2022-02-16 Option Award | 2022-02-18 4:44 pm | N/A 2032-02-16 | Pear Therapeutics Inc. | PEAR | Brenner Erin K. Chief Product Dev. Officer | 119,187 | $0 | 119,187 (Direct) | View |
| 2021-12-03 Option Award | 2021-12-07 5:24 pm | N/A 2028-09-20 | Pear Therapeutics Inc. | PEAR | Brenner Erin K. Chief Product Dev. Officer | 399,987 | $0 | 399,987 (Direct) | View |